Verve Therapeutics Income Statement

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Revenue	969	862	661	383.1	319.5	254.25
Revenue Growth (YoY)	33.29%	30.41%	72.54%	19.91%	25.66%	-
Cost of Revenue	863	771	565	311.8	250.39	193.94
Gross Profit	106	91	96	71.3	69.11	60.3
Selling, General & Admin	77	77	57	44	27.34	21.15
Research & Development	36	36	19	16	10.75	6.77
Other Operating Expenses	-8	-5	-5	1.3	4.2	5.9
Operating Expenses	105	108	71	61.3	42.28	33.83
Operating Income	1	-17	25	10	26.83	26.48
Interest Expense	-1	-	-	-0.1	-0.12	-0.16
Interest & Investment Income	25	26	11	1.1	0.48	1.13
Currency Exchange Gain (Loss)	-	-	-	-1.4	0.05	0.23
Other Non Operating Income (Expenses)	1	-	-	1	-0.49	-0.09
EBT Excluding Unusual Items	26	9	36	10.6	26.74	27.58
Gain (Loss) on Sale of Assets	-	-	-	-	-0.03	-0
Pretax Income	29	12	36	10.6	26.72	27.57
Income Tax Expense	5	1	12	4.6	5.42	5.91
Net Income	24	11	24	6	21.29	21.67
Net Income to Common	24	11	24	6	21.29	21.67
Net Income Growth	389.80%	-54.17%	300.00%	-71.82%	-1.73%	-
Shares Outstanding (Basic)	126	126	106	100	100	100
Shares Outstanding (Diluted)	126	126	106	100	100	100
Shares Change (YoY)	5.88%	18.87%	6.00%	-	-	-
EPS (Basic)	0.19	0.09	0.23	0.06	0.21	0.22
EPS (Diluted)	0.19	0.09	0.23	0.06	0.21	0.22
EPS Growth	362.59%	-61.44%	277.36%	-71.82%	-1.73%	-
Free Cash Flow	-32	-68	-17	86.1	36.5	2.53
Free Cash Flow Per Share	-0.25	-0.54	-0.16	0.86	0.36	0.03
Gross Margin	10.94%	10.56%	14.52%	18.61%	21.63%	23.72%
Operating Margin	0.10%	-1.97%	3.78%	2.61%	8.40%	10.41%
Profit Margin	2.48%	1.28%	3.63%	1.57%	6.67%	8.52%
Free Cash Flow Margin	-3.30%	-7.89%	-2.57%	22.48%	11.43%	0.99%
EBITDA	6	-14	26	10.8	27.95	27.7
EBITDA Margin	0.62%	-1.62%	3.93%	2.82%	8.75%	10.90%
D&A For EBITDA	5	3	1	0.8	1.13	1.23
EBIT	1	-17	25	10	26.83	26.48
EBIT Margin	0.10%	-1.97%	3.78%	2.61%	8.40%	10.41%
Effective Tax Rate	17.24%	8.33%	33.33%	43.40%	20.29%	21.42%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.